Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2

Conditions

Febrile Neutropenia 5Neoplasms 3Neutropenia 2Fever 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Neoplasms 1

Interventions

pegfilgrastim 3Vancomycin 2Teicoplanin 2Meropenem 2Filgrastim 2Ciprofloxacin 2Ceftazidime 2Cefepime 2posaconazole 1pegylated granulocyte colony-stimulating factor 1Vascular Access Devices 1Ofloxacin 1Metronidazole 1Leucovorin 1Lenograstim 1Irinotecan 1Fluorouracil 1Cilastatin, Imipenem Drug Combination 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neutropenia × Ceftazidime × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT04187755 2019-12-06

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Indonesia University

Phase 4 Completed
72 enrolled
Classical hematologyOther hematologic neoplasm

Fever, Leukemia, Neoplasms, Neutropenia, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡